Related Experiment Video
Updated: Jan 4, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device
Salvador R Maffei1, Harveen K Lamba2, Cassius Kwasi Mensah2
1Division of Cardiothoracic Transplantation and Circulatory Support, Baylor College of Medicine, Houston, Texas.
Abstract:
Anticoagulation with unfractionated heparin is vital to reduce the risk of thromboembolic events during cardiopulmonary bypass and left ventricular assist device placement. However patients with heparin-induced thrombocytopenia are at risk of developing immune-mediated thrombotic events. We describe 2 patients with heparin-induced thrombocytopenia confirmed via serotonin release assay who were successfully treated with plasmapheresis exchange before left ventricular assist device placement.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Hemodialysis I: Introduction
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies

